Schelpe AS et al. (2020), Antibodies that conformationally activate ADAMT...

ECB-ART-48511

Blood Adv 2020 Mar 24;46:1072-1080. doi: 10.1182/bloodadvances.2019001375.

Show Gene links Show Anatomy links

Antibodies that conformationally activate ADAMTS13 allosterically enhance metalloprotease domain function.

Schelpe AS , Petri A , Roose E , Pareyn I , Deckmyn H , De Meyer SF , Crawley JTB , Vanhoorelbeke K .

???displayArticle.abstract???
Plasma ADAMTS13 circulates in a folded conformation that is stabilized by an interaction between the central Spacer domain and the C-terminal CUB (complement components C1r and C1s, sea urchin protein Uegf, and bone morphogenetic protein-1) domains. Binding of ADAMTS13 to the VWF D4(-CK) domains or to certain activating murine monoclonal antibodies (mAbs) induces a structural change that extends ADAMTS13 into an open conformation that enhances its function. The objective was to characterize the mechanism by which conformational activation enhances ADAMTS13-mediated proteolysis of VWF. The activating effects of a novel anti-Spacer (3E4) and the anti-CUB1 (17G2) mAbs on the kinetics of proteolysis of VWF A2 domain fragments by ADAMTS13 were analyzed. mAb-induced conformational changes in ADAMTS13 were investigated by enzyme-linked immunosorbent assay. Both mAbs enhanced ADAMTS13 catalytic efficiency (kcat/Km) by ∼twofold (3E4: 2.0-fold; 17G2: 1.8-fold). Contrary to previous hypotheses, ADAMTS13 activation was not mediated through exposure of the Spacer or cysteine-rich domain exosites. Kinetic analyses revealed that mAb-induced conformational extension of ADAMTS13 enhances the proteolytic function of the metalloprotease domain (kcat), rather than augmenting substrate binding (Km). A conformational effect on the metalloprotease domain was further corroborated by the finding that incubation of ADAMTS13 with either mAb exposed a cryptic epitope in the metalloprotease domain that is normally concealed when ADAMTS13 is in a closed conformation. We show for the first time that the primary mechanism of mAb-induced conformational activation of ADAMTS13 is not a consequence of functional exosite exposure. Rather, our data are consistent with an allosteric activation mechanism on the metalloprotease domain that augments active site function.

???displayArticle.pubmedLink??? 32196558
???displayArticle.pmcLink??? PMC7094026
???displayArticle.link??? Blood Adv
???displayArticle.grants??? [+]

Genes referenced: LOC100887844 LOC582189 LOC582915 LOC591473

References [+] :

Akiyama, Crystal structures of the noncatalytic domains of ADAMTS13 reveal multiple discontinuous exosites for von Willebrand factor. 2009, Pubmed

Akiyama, Crystal structures of the noncatalytic domains of ADAMTS13 reveal multiple discontinuous exosites for von Willebrand factor. 2009, Pubmed
Crawley, Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor. 2011, Pubmed
Deforche, Linker regions and flexibility around the metalloprotease domain account for conformational activation of ADAMTS-13. 2015, Pubmed
Feys, Thrombotic thrombocytopenic purpura directly linked with ADAMTS13 inhibition in the baboon (Papio ursinus). 2010, Pubmed
Jian, Gain-of-function ADAMTS13 variants that are resistant to autoantibodies against ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura. 2012, Pubmed
Kokame, FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay. 2005, Pubmed
Muia, Allosteric activation of ADAMTS13 by von Willebrand factor. 2014, Pubmed , Echinobase
Muia, Phylogenetic and functional analysis of ADAMTS13 identifies highly conserved domains essential for allosteric regulation. 2019, Pubmed , Echinobase
Petri, Crystal structure and substrate-induced activation of ADAMTS13. 2019, Pubmed
Roose, An open conformation of ADAMTS-13 is a hallmark of acute acquired thrombotic thrombocytopenic purpura. 2018, Pubmed
South, Conformational activation of ADAMTS13. 2014, Pubmed
South, A model for the conformational activation of the structurally quiescent metalloprotease ADAMTS13 by von Willebrand factor. 2017, Pubmed
Zanardelli, A novel binding site for ADAMTS13 constitutively exposed on the surface of globular VWF. 2009, Pubmed
Zhang, Mechanoenzymatic cleavage of the ultralarge vascular protein von Willebrand factor. 2009, Pubmed
Zheng, Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura. 2001, Pubmed
de Groot, The role of the ADAMTS13 cysteine-rich domain in VWF binding and proteolysis. 2015, Pubmed